Get started
Author

Katrin Frenzel

Actively personalized vaccination trial for newly diagnosed glioblastoma
2018 · Norbert Hilf, Sabrina Kuttruff-Coqui, et al. · Nature · 948
Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
2010 · Claudia Michael, Uta Bierbach, et al. · Antimicrobial Agents and Chemotherapy · 79
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
2019 · Bracha Shraibman, Eilon Barnea, et al. · Molecular & Cellular Proteomics · 67
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
2018 · Bracha Shraibman, Eilon Barnea, et al. · Molecular & Cellular Proteomics · 64
Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis
2011 · C. Otto, A. Oltmann, et al. · Neurology · 49
GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma.
2018 · Wolfgang Wick, Pierre-Yves Dietrich, et al. · Journal of Clinical Oncology · 28
Moraxella catarrhalis decreases antiviral innate immune responses by down‐regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells
2016 · Annina Heinrich, Helge Haarmann, et al. · The FASEB Journal · 23
Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis
2010 · Joerg Hofmann, Katrin Frenzel, et al. · Diagnostic Microbiology and Infectious Disease · 23
Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines
2012 · K. Frenzel, S. Ganepola, et al. · Medical Microbiology and Immunology · 21
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
2019 · Norbert Hilf, Sabrina Kuttruff-Coqui, et al. · Nature · 15
PDF
Determination of Saliva Trough Levels for Monitoring Voriconazole Therapy in Immunocompromised Children and Adults
2010 · Claudia Michael, Uta Bierbach, et al. · Therapeutic Drug Monitoring · 12
Abstract OT2-06-01: Highly innovative personalized RNA-immunotherapy for patients with triple negative breast cancer
2019 · M Schmidt, S Bolte, et al. · Cancer Research · 10
Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection
2013 · K. Frenzel, J. Lehmann, et al. · Medical Microbiology and Immunology · 10
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2018 · L. Heesen, K. Frenzel, et al. · Annals of Oncology · 4
Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2019 · Ludwig Heesen, Katrin Frenzel, et al. · Cancer Research · 3
Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2019 · Ludwig Heesen, Katrin Frenzel, et al. · Clinical Trials · 2
Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma.
2019 · Bracha Shraibman, Eilon Barnea, et al. · Molecular & Cellular Proteomics · 2
PDF
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer
2017 · K. Frenzel, L. Heesen, et al. · Annals of Oncology · 2
PDF
699 Updated safety, PK/PD, and efficacy results from the dose escalation part of a phase I clinical trial of BNT411, a systemic Toll-like receptor 7 agonist, in patients with advanced solid tumors
2024 · Devalingam Mahalingam, Stefan Symeonides, et al. · Journal for ImmunoTherapy of Cancer · 1
Atim-20. Gapvac-101 Trial of a Highly Personalized Peptide Vaccination for Patients With Newly Diagnosed Glioblastoma
2018 · Wolfgang Wick, Pierre-Yves Dietrich, et al. · Neuro-Oncology · 1
PDF
Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma
2016 · Norbert Hilf, Katrin Frenzel, et al. · Cancer Research · 1
Abstract CT201: The Mutanome Engineered RNA Immuno-Therapy (MERIT) project
2015 · Sandra Heesch, Cedrik M. Britten, et al. · Cancer Research · 1
Setting up a perfusion process in ambr®15 to produce lentiviral vectors
2021 · Alexander Tappe, Katrin Frenzel, et al.
Setting up a perfusion process in ambr®15 to produce lentiviral vectors
2021 · Alexander Tappe, Katrin Frenzel, et al.
Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma
2019 · Alexander Ulges, Norbert Hilf, et al. · Cancer Immunology Research
Works count: 27
Citation count: 1,366
H-index: 11
I10-index: 13
Year
Topic
Type